Ultrorelix 0.25mg Injection
Prescription Required
Product introduction
Ultrorelix 0.25mg Injection is an anti-gonadotropin-releasing hormone medicine. It is used in the treatment of infertility in females. It restricts eggs to release directly and prevents premature ovulation.
Ultrorelix 0.25mg Injection is used during techniques in women that help them in getting pregnant
Ultrorelix 0.25mg Injection is used during techniques in women that help them in getting pregnant
Uses of Ultrorelix Injection
Benefits of Ultrorelix Injection
In Female infertility
Ultrorelix 0.25mg Injection prevents release of premature eggs during a process called ovulation in females. This helps in normal development of an egg in a woman's ovary (female reproductive organ), and stimulates the release of a healthy, matured egg. This helps to treat infertility in women and increases the chance of a successful pregnancy. It is given as an injection by a doctor or nurse and should not be self-administered. You should use the medicine as prescribed for it to be effective.
Side effects of Ultrorelix Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Ultrorelix
- Nausea
- Ovarian hyperstimulation syndrome
- Injection site reactions (pain, swelling, redness)
- Itching
- Irritation
- Vomiting
- Lower abdominal pain
How to use Ultrorelix Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Safety advice
Alcohol
CAUTION
Caution is advised when consuming alcohol with Ultrorelix 0.25mg Injection. Please consult your doctor.
Pregnancy
UNSAFE
Ultrorelix 0.25mg Injection is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
Breast feeding
UNSAFE
Ultrorelix 0.25mg Injection is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Driving
SAFE
Ultrorelix 0.25mg Injection does not usually affect your ability to drive.
Kidney
CAUTION
Ultrorelix 0.25mg Injection should be used with caution in patients with kidney disease. Dose adjustment of Ultrorelix 0.25mg Injection may be needed. Please consult your doctor.
However, the use of Ultrorelix 0.25mg Injection is not recommended in patients with severe kidney disease.
However, the use of Ultrorelix 0.25mg Injection is not recommended in patients with severe kidney disease.
Liver
CAUTION
Ultrorelix 0.25mg Injection should be used with caution in patients with liver disease. Dose adjustment of Ultrorelix 0.25mg Injection may be needed. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Ultrorelix 0.25mg Injection
₹1200.0/Injection
Cetrolix 0.25mg Injection
Intas Pharmaceuticals Ltd
₹1307/injection
9% costlier
Ciscure 0.25mg Injection
Emcure Pharmaceuticals Ltd
₹1217.62/injection
1% costlier
Ovucet 0.25mg Injection
Zydus Cadila
₹1271.5/injection
6% costlier
Vestova 0.25mg Injection
Alkem Laboratories Ltd
₹1239/injection
3% costlier
Cetide 0.25mg Injection
LG Lifesciences
₹650/injection
46% cheaper
Quick tips
- Ultrorelix 0.25mg Injection helps prevent premature ovulation in women undergoing assisted reproduction treatments such as IVF.
- It is given as an injection under the skin (subcutaneously), preferably of the upper leg.
- Inform your doctor immediately if you get very dizzy, faint, vomit, or have diarrhea while using this medicine. These could be symptoms of ovarian hyperstimulation syndrome (OHSS).
- Do not use this medicine if you are already pregnant or breastfeeding.
Fact Box
Chemical Class
Polypeptides
Habit Forming
No
Therapeutic Class
HORMONES
Action Class
GNRH antagonists
Patient concerns
FAQs
What is Ultrorelix 0.25mg Injection and for what it is used for?
Ultrorelix 0.25mg Injection is an injectable preparation, which contains the active substance Ganirelix. It is used in women undergoing certain fertility treatments. It acts by blocking the release of luteinizing hormone (LH) thus preventing eggs from being released too early and gives the eggs time to grow properly. It is usually used in combination with other medicines.
How and in what dose can it be used?
It is given as an injection, only at the hospital or clinic by the medical healthcare professional. The patient may be monitored regularly for the follicular development. The treatment duration depends on the ovarian response of the patient.
What may be the possible side effects associated with it?
The most common side effect is local site reaction (redness of skin with or without swelling). You may also feel a headache or nausea. However, these effects are temporary, if these persist consult with your doctor. In addition, conditions like ovarian hyperstimulation syndrome (OHSS), and multiple births or birth defect, may also be associated with the use of this medicine.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Masters SB. Hypothalmic & Pituitary Hormones. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 655.
- Medscape. Cetrorelix. [Accessed 03 Apr. 2019] (online) Available from:
- FDA. Ganirelix Acetate Injection. [Accessed 29 Jan. 2019] (online) Available from:
- Cetrorelix acetate. Rockland, Massachusetts: EMD Serono, Inc.; 2008. [Accessed 08 Feb. 2019] (online) Available from:
Marketer details
Name: Glenmark Pharmaceuticals Ltd
Address: Glenmark Pharmaceuticals Limited, B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026.
Country of origin: India
Lab tests offered by us
Related/Popular tests
22 people viewed this recentlyDISCONTINUED
We do not facilitate sale of this product at present